Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Reuters11-12

Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582795233?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582795233","market":"us","top_or_hot":-1,"title":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Syra Health Reports Q3 Revenue Growth and Reduced Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSyra Health Reports Q3 Revenue Growth and Reduced Net Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-12 20:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2pP1gt:1","article_id":"2582795233","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582795233","pubTimestamp":1762952134,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to , compared to  in Q3 2024, due to improved operational efficiency. Earnings per share improved to  in Q3 2025 from  in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","SYRA":"Syra Health Corp."},"translate_title":"Syra Health报告第三季度收入增长并减少净亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRA":0.9},"content_text":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    \n\nSyra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582795233","isCrawlerRequest":true}